Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

47.41
+1.773.88%
Post-market: 47.410.00000.00%16:05 EDT
Volume:1.74M
Turnover:81.72M
Market Cap:5.85B
PE:-13.34
High:47.60
Open:46.06
Low:44.50
Close:45.64
Loading ...

Guardant Health Base Business in 'Fundamentally Good Shape,' Morgan Stanley Says

MT Newswires Live
·
07 Mar

Morgan Stanley Adjusts Price Target on Guardant Health to $52 From $42, Keeps Overweight Rating

MT Newswires Live
·
06 Mar

Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities

Business Wire
·
05 Mar

GH Research’s Promising Growth Potential: Buy Rating Backed by Strong Clinical Data and Financial Position

TIPRANKS
·
04 Mar

Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue

StockStory
·
04 Mar

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025

Insider Monkey
·
04 Mar

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
02 Mar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
01 Mar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
01 Mar

Promising Trial Results and Strong Financials Justify Buy Rating for GH Research

TIPRANKS
·
28 Feb

Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Cullinan Management (CGEM)

TIPRANKS
·
28 Feb

Psychedelic: GH Research, Compass Pathways report earnings results

TIPRANKS
·
28 Feb

GH Research Is Maintained at Buy by Stifel

Dow Jones
·
27 Feb

New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change

Business Wire
·
27 Feb

GH Research 2024 GAAP EPS $(0.75), Down From $(0.68) YoY

Benzinga
·
27 Feb

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
27 Feb

Guardant Health Is Maintained at Overweight by Piper Sandler

Dow Jones
·
27 Feb

Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts

Insider Monkey
·
27 Feb

Stock Track | Guardant Health Soars 5.08% as Piper Sandler Raises Price Target

Stock Track
·
26 Feb

Guardant Health price target raised to $50 from $34 at Piper Sandler

TIPRANKS
·
26 Feb